scispace - formally typeset
M

Masakazu Yamagishi

Researcher at Osaka University of Human Sciences

Publications -  611
Citations -  19862

Masakazu Yamagishi is an academic researcher from Osaka University of Human Sciences. The author has contributed to research in topics: Percutaneous coronary intervention & Acute coronary syndrome. The author has an hindex of 62, co-authored 604 publications receiving 17939 citations. Previous affiliations of Masakazu Yamagishi include Kanazawa University & Toshiba.

Papers
More filters
Journal ArticleDOI

Transplantation of Mesenchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy

TL;DR: MSC transplantation improved cardiac function in a rat model of DCM, possibly through induction of myogenesis and angiogenesis, as well as by inhibition of myocardial fibrosis.
Journal ArticleDOI

Very high-mobility organic single-crystal transistors with in-crystal conduction channels

TL;DR: Very high-mobility organic transistors are fabricated with purified rubrene single crystals and high-density organosilane self-assembled monolayers in this paper, where the interface with minimized surface levels allows carriers to distribute deep into the crystals by more than a few molecular layers under weak gate electric fields, and the inner channel plays a significant part in the transfer performance.
Journal ArticleDOI

Hemodynamic and hormonal effects of human ghrelin in healthy volunteers

TL;DR: Human ghrelin elicited a potent, long-lasting GH release and had beneficial hemodynamic effects via reducing cardiac afterload and increasing cardiac output without an increase in heart rate.
Journal ArticleDOI

New method for evaluating left ventricular wall motion by color-coded tissue Doppler imaging : in vitro and in vivo studies

TL;DR: Results indicate that the present tissue Doppler imaging system accurately represents tissue velocity and can create two-dimensional color images that facilitate visual assessment of ventricular wall motion.
Journal ArticleDOI

Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis.

TL;DR: Results suggest that intravenous administration of MSCs improves cardiac function after acute myocardial infarction through enhancement of angiogenesis and myogenesis in the ischemic myocardium.